Demographic Composition of Select Oncologic New Molecular Entities Approved by the FDA Between 2008 and 2017

Clinical Pharmacology and Therapeutics - United States
doi 10.1002/cpt.1180
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Wiley

Related search

Drug Development Process and Novel Drugs Approved by FDA for 2017 -18

Applied Clinical Research, Clinical Trials and Regulatory Affairs
2018English

From the FDA: New Glucose Monitoring System Approved

Journal of the American Osteopathic Association, The
MedicineAlternative MedicineComplementary
1999English

Reverse Translation of US Food and Drug Administration Reviews of Oncology New Molecular Entities Approved in 2011-2017: Lessons Learned for Anticancer Drug Development

Clinical and Translational Science
GeneticsMolecular BiologyPharmacologyBiochemistryNeuroscienceMedicineToxicologyPharmaceutics
2017English

FDA-Approved Biosimilar Insulin

Journal of diabetes science and technology
Internal MedicineEndocrinologyBioengineeringBiomedical EngineeringMetabolismDiabetes
2014English

A Review on the Drugs Approved by US-FDA and DCGI

TEXILA INTERNATIONAL JOURNAL OF CLINICAL RESEARCH
2016English

From the FDA: Heart Pump Approved

Journal of the American Osteopathic Association, The
MedicineAlternative MedicineComplementary
1994English

From the FDA: Epilepsy Drug Approved

Journal of the American Osteopathic Association, The
MedicineAlternative MedicineComplementary
1994English

From the FDA: Testosterone Patch Approved

Journal of the American Osteopathic Association, The
MedicineAlternative MedicineComplementary
1995English

From the FDA: Chickenpox Vaccine Approved

Journal of the American Osteopathic Association, The
MedicineAlternative MedicineComplementary
1995English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy